Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.
Varex Imaging Corporation (NASDAQ: VREX) is a designer and manufacturer of X-ray imaging components and systems used in medical, industrial, and security applications. The VREX news page on Stock Titan aggregates company announcements, earnings releases, conference presentations, and product-related updates so readers can follow how the business is evolving over time.
Recent news for Varex has focused on quarterly and annual financial results, including detailed segment reporting for its Medical and Industrial businesses, as well as reconciliations between GAAP and non-GAAP financial measures. Earnings releases typically discuss revenue trends in medical X-ray components, demand in industrial imaging, and developments affecting specific markets such as China. Management commentary often highlights factors such as segment performance, margins, cash flow from operations, and capital structure items like convertible notes and senior secured notes.
In addition to financial results, Varex issues news about orders and deployments of its high-energy non-intrusive cargo and vehicle inspection systems. These announcements describe international customers placing systems at strategic sea and land ports and reference the company’s reputation in high-energy Linear Accelerator based imaging. The news flow also includes updates on investor conference appearances, where management presents at events hosted by firms such as CJS Securities, Sidoti, and Jefferies.
Visitors to the VREX news page can use this stream of press releases and updates to monitor trends in medical imaging components, industrial and security imaging systems, cargo inspection orders, and corporate developments. Bookmarking the page allows investors and observers to review new announcements alongside prior releases for context on Varex Imaging Corporation’s ongoing disclosures.
Varex Imaging (Nasdaq: VREX) has announced its schedule for reporting third quarter fiscal year 2024 unaudited financial results. The earnings release will be on Thursday, August 1, 2024, after regular trading hours, followed by a conference call at 3:00 pm Mountain Time. Investors can access the call via webcast or phone, with replay options available until August 15th.
Varex, with a 70+ year history, is a leading innovator in X-ray imaging components, including X-ray tubes, digital detectors, and image processing solutions. The company's products are used in medical, industrial, and security imaging applications. Varex employs about 2,300 people globally and is headquartered in Salt Lake City, Utah.
Varex Imaging (Nasdaq: VREX) announced its participation in three upcoming investor conferences. The company's management will attend the Jefferies Global Healthcare Conference in New York on June 6, 2024, at 9:00 am ET, the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 10, 2024 (1x1 meetings only), and the Sidoti June 2024 Virtual Small Cap Conference on June 13, 2024, at 10:45 am ET. These events can be accessed via the Varex Imaging website.
Varex Imaging (Nasdaq: VREX) announced its unaudited financial results for the second quarter of fiscal year 2024, with revenues of $206 million. The GAAP gross margin was 32%, while the Non-GAAP gross margin stood at 33%. GAAP net earnings were $0.03 per diluted share, and Non-GAAP net earnings were $0.16 per diluted share. Cash flow from operations was $3 million. The company reported a 10% year-over-year decrease in revenue, primarily due to lower sales in China. The medical segment revenue was down 15%, while the industrial segment revenue was up 6%. Non-GAAP gross margin was 33%, with Non-GAAP EPS decreasing to $0.16 from $0.26 in the previous year. Cash, cash equivalents, marketable securities, and CDs totaled $190 million at the end of the quarter. The company provided guidance for the third quarter, expecting revenues between $200 million and $220 million and Non-GAAP net earnings per diluted share between $0.05 and $0.25.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.